Detailed Mechanism Funding and Narrative

Years of mechanism: 2017 2018

Details for Mechanism ID: 18496
Country/Region: Kenya
Year: 2018
Main Partner: Johns Hopkins University
Main Partner Program: JHPIEGO
Organizational Type: University
Funding Agency: USAID
Total Funding: $7,551,081 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $0
Care: Orphans and Vulnerable Children (HKID) $0
Care: TB/HIV (HVTB) $0
Care: Pediatric Care and Support (PDCS) $0
Laboratory Infrastructure (HLAB) $0
Strategic Information (HVSI) $0
Health Systems Strengthening (OHSS) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $0
Biomedical Prevention: Blood Safety (HMBL) $0
Biomedical Prevention: Injection Safety (HMIN) $0
Sexual Prevention: Abstinence/Be Faithful (HVAB) $433,065
Prevention: HIV Testing and Counseling (HVCT) $1,109,177
Sexual Prevention: Other Sexual Prevention (HVOP) $461,225
Prevention: Injecting and Non-Injecting Drug Use (IDUP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $749,504
Treatment: ARV Drugs (HTXD) $0
Treatment: Adult Treatment (HTXS) $4,450,000
Treatment: Pediatric Treatment (PDTX) $348,110
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV_DSD 10-14, Female, Physical and/or Emotional Violence 2019 450
GEND_GBV_DSD 10-14, Female, Sexual Violence (Post-Rape Care) 2019 450
GEND_GBV_DSD 10-14, Male, Physical and/or Emotional Violence 2019 150
GEND_GBV_DSD 10-14, Male, Sexual Violence (Post-Rape Care) 2019 150
GEND_GBV_DSD 15-19, Female, Physical and/or Emotional Violence 2019 1,503
GEND_GBV_DSD 15-19, Female, Sexual Violence (Post-Rape Care) 2019 1,503
GEND_GBV_DSD 15-19, Male, Physical and/or Emotional Violence 2019 150
GEND_GBV_DSD 15-19, Male, Sexual Violence (Post-Rape Care) 2019 150
GEND_GBV_DSD 20-24, Female, Physical and/or Emotional Violence 2019 2,104
GEND_GBV_DSD 20-24, Female, Sexual Violence (Post-Rape Care) 2019 2,104
GEND_GBV_DSD 20-24, Male, Physical and/or Emotional Violence 2019 150
GEND_GBV_DSD 20-24, Male, Sexual Violence (Post-Rape Care) 2019 150
GEND_GBV_DSD 50+, Female, Physical and/or Emotional Violence 2019 150
GEND_GBV_DSD 50+, Female, Sexual Violence (Post-Rape Care) 2019 150
GEND_GBV_DSD 50+, Male, Physical and/or Emotional Violence 2019 150
GEND_GBV_DSD 50+, Male, Sexual Violence (Post-Rape Care) 2019 150
GEND_GBV_DSD <10, Female, Physical and/or Emotional Violence 2019 150
GEND_GBV_DSD <10, Female, Sexual Violence (Post-Rape Care) 2019 150
GEND_GBV_DSD <10, Male, Physical and/or Emotional Violence 2019 150
GEND_GBV_DSD <10, Male, Sexual Violence (Post-Rape Care) 2019 150
GEND_GBV_DSD By PEP service provision (related to sexual violence services provided) 2019 6,352
GEND_GBV_DSD By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2019 7,519
GEND_GBV_DSD By type of service: Sexual Violence (Post-Rape Care) 2019 7,517
GEND_GBV_DSD GEND_GBV_N_DSD_Age_Sex_ViolenceType_v3 25-29, Female, Physical and/or Emotional Violence 2019 450
GEND_GBV_DSD GEND_GBV_N_DSD_Age_Sex_ViolenceType_v3 25-29, Female, Sexual Violence (Post-Rape Care) 2019 450
GEND_GBV_DSD GEND_GBV_N_DSD_Age_Sex_ViolenceType_v3 25-29, Male, Physical and/or Emotional Violence 2019 150
GEND_GBV_DSD GEND_GBV_N_DSD_Age_Sex_ViolenceType_v3 25-29, Male, Sexual Violence (Post-Rape Care) 2019 150
GEND_GBV_DSD GEND_GBV_N_DSD_Age_Sex_ViolenceType_v3 30-34, Female, Physical and/or Emotional Violence 2019 450
GEND_GBV_DSD GEND_GBV_N_DSD_Age_Sex_ViolenceType_v3 30-34, Female, Sexual Violence (Post-Rape Care) 2019 450
GEND_GBV_DSD GEND_GBV_N_DSD_Age_Sex_ViolenceType_v3 30-34, Male, Physical and/or Emotional Violence 2019 150
GEND_GBV_DSD GEND_GBV_N_DSD_Age_Sex_ViolenceType_v3 30-34, Male, Sexual Violence (Post-Rape Care) 2019 150
GEND_GBV_DSD GEND_GBV_N_DSD_Age_Sex_ViolenceType_v3 35-39, Female, Physical and/or Emotional Violence 2019 450
GEND_GBV_DSD GEND_GBV_N_DSD_Age_Sex_ViolenceType_v3 35-39, Female, Sexual Violence (Post-Rape Care) 2019 450
GEND_GBV_DSD GEND_GBV_N_DSD_Age_Sex_ViolenceType_v3 35-39, Male, Physical and/or Emotional Violence 2019 150
GEND_GBV_DSD GEND_GBV_N_DSD_Age_Sex_ViolenceType_v3 35-39, Male, Sexual Violence (Post-Rape Care) 2019 150
GEND_GBV_DSD GEND_GBV_N_DSD_Age_Sex_ViolenceType_v3 40-49, Female, Physical and/or Emotional Violence 2019 450
GEND_GBV_DSD GEND_GBV_N_DSD_Age_Sex_ViolenceType_v3 40-49, Female, Sexual Violence (Post-Rape Care) 2019 456
GEND_GBV_DSD GEND_GBV_N_DSD_Age_Sex_ViolenceType_v3 40-49, Male, Physical and/or Emotional Violence 2019 150
GEND_GBV_DSD GEND_GBV_N_DSD_Age_Sex_ViolenceType_v3 40-49, Male, Sexual Violence (Post-Rape Care) 2019 150
GEND_GBV_DSD Number of people receiving post-GBV care 2019 15,030
HTC_TST_DSD HTS_TST_N_DSD_Index_Age_Sex_Result 25-29, Female, Negative 2019 735
HTC_TST_DSD HTS_TST_N_DSD_Index_Age_Sex_Result 25-29, Female, Positive 2019 259
HTC_TST_DSD HTS_TST_N_DSD_Index_Age_Sex_Result 25-29, Male, Negative 2019 163
HTC_TST_DSD HTS_TST_N_DSD_Index_Age_Sex_Result 25-29, Male, Positive 2019 53
HTC_TST_DSD HTS_TST_N_DSD_Index_Age_Sex_Result 30-34, Female, Negative 2019 849
HTC_TST_DSD HTS_TST_N_DSD_Index_Age_Sex_Result 30-34, Female, Positive 2019 291
HTC_TST_DSD HTS_TST_N_DSD_Index_Age_Sex_Result 30-34, Male, Negative 2019 195
HTC_TST_DSD HTS_TST_N_DSD_Index_Age_Sex_Result 30-34, Male, Positive 2019 66
HTC_TST_DSD HTS_TST_N_DSD_Index_Age_Sex_Result 35-39, Female, Negative 2019 207
HTC_TST_DSD HTS_TST_N_DSD_Index_Age_Sex_Result 35-39, Female, Positive 2019 73
HTC_TST_DSD HTS_TST_N_DSD_Index_Age_Sex_Result 35-39, Male, Negative 2019 198
HTC_TST_DSD HTS_TST_N_DSD_Index_Age_Sex_Result 35-39, Male, Positive 2019 65
HTC_TST_DSD HTS_TST_N_DSD_Index_Age_Sex_Result 40-49, Female, Negative 2019 210
HTC_TST_DSD HTS_TST_N_DSD_Index_Age_Sex_Result 40-49, Female, Positive 2019 74
HTC_TST_DSD HTS_TST_N_DSD_Index_Age_Sex_Result 40-49, Male, Negative 2019 64
HTC_TST_DSD HTS_TST_N_DSD_Index_Age_Sex_Result 40-49, Male, Positive 2019 19
HTC_TST_DSD HTS_TST_N_DSD_Inpat_Age_Sex_Result 25-29, Female, Negative 2019 2,964
HTC_TST_DSD HTS_TST_N_DSD_Inpat_Age_Sex_Result 25-29, Female, Positive 2019 82
HTC_TST_DSD HTS_TST_N_DSD_Inpat_Age_Sex_Result 25-29, Male, Negative 2019 645
HTC_TST_DSD HTS_TST_N_DSD_Inpat_Age_Sex_Result 25-29, Male, Positive 2019 12
HTC_TST_DSD HTS_TST_N_DSD_Inpat_Age_Sex_Result 30-34, Female, Negative 2019 3,503
HTC_TST_DSD HTS_TST_N_DSD_Inpat_Age_Sex_Result 30-34, Female, Positive 2019 88
HTC_TST_DSD HTS_TST_N_DSD_Inpat_Age_Sex_Result 30-34, Male, Negative 2019 782
HTC_TST_DSD HTS_TST_N_DSD_Inpat_Age_Sex_Result 30-34, Male, Positive 2019 17
HTC_TST_DSD HTS_TST_N_DSD_Inpat_Age_Sex_Result 35-39, Female, Negative 2019 875
HTC_TST_DSD HTS_TST_N_DSD_Inpat_Age_Sex_Result 35-39, Female, Positive 2019 21
HTC_TST_DSD HTS_TST_N_DSD_Inpat_Age_Sex_Result 35-39, Male, Negative 2019 780
HTC_TST_DSD HTS_TST_N_DSD_Inpat_Age_Sex_Result 35-39, Male, Positive 2019 17
HTC_TST_DSD HTS_TST_N_DSD_Inpat_Age_Sex_Result 40-49, Female, Negative 2019 875
HTC_TST_DSD HTS_TST_N_DSD_Inpat_Age_Sex_Result 40-49, Female, Positive 2019 22
HTC_TST_DSD HTS_TST_N_DSD_Inpat_Age_Sex_Result 40-49, Male, Negative 2019 266
HTC_TST_DSD HTS_TST_N_DSD_Inpat_Age_Sex_Result 40-49, Male, Positive 2019 6
HTC_TST_DSD HTS_TST_N_DSD_NdxMod_Age_Sex_Result 25-29, Female, Negative 2019 18
HTC_TST_DSD HTS_TST_N_DSD_NdxMod_Age_Sex_Result 25-29, Female, Positive 2019 2
HTC_TST_DSD HTS_TST_N_DSD_NdxMod_Age_Sex_Result 25-29, Male, Negative 2019 1
HTC_TST_DSD HTS_TST_N_DSD_NdxMod_Age_Sex_Result 30-34, Female, Negative 2019 20
HTC_TST_DSD HTS_TST_N_DSD_NdxMod_Age_Sex_Result 30-34, Female, Positive 2019 2
HTC_TST_DSD HTS_TST_N_DSD_NdxMod_Age_Sex_Result 30-34, Male, Negative 2019 1
HTC_TST_DSD HTS_TST_N_DSD_NdxMod_Age_Sex_Result 35-39, Female, Negative 2019 5
HTC_TST_DSD HTS_TST_N_DSD_NdxMod_Age_Sex_Result 35-39, Female, Positive 2019 1
HTC_TST_DSD HTS_TST_N_DSD_NdxMod_Age_Sex_Result 35-39, Male, Negative 2019 1
HTC_TST_DSD HTS_TST_N_DSD_NdxMod_Age_Sex_Result 40-49, Female, Negative 2019 5
HTC_TST_DSD HTS_TST_N_DSD_NdxMod_Age_Sex_Result 40-49, Female, Positive 2019 1
HTC_TST_DSD HTS_TST_N_DSD_OtPITC_Age_Sex_Result 25-29, Female, Negative 2019 20,597
HTC_TST_DSD HTS_TST_N_DSD_OtPITC_Age_Sex_Result 25-29, Female, Positive 2019 598
HTC_TST_DSD HTS_TST_N_DSD_OtPITC_Age_Sex_Result 25-29, Male, Negative 2019 15,666
HTC_TST_DSD HTS_TST_N_DSD_OtPITC_Age_Sex_Result 25-29, Male, Positive 2019 438
HTC_TST_DSD HTS_TST_N_DSD_OtPITC_Age_Sex_Result 30-34, Female, Negative 2019 23,244
HTC_TST_DSD HTS_TST_N_DSD_OtPITC_Age_Sex_Result 30-34, Female, Positive 2019 674
HTC_TST_DSD HTS_TST_N_DSD_OtPITC_Age_Sex_Result 30-34, Male, Negative 2019 18,548
HTC_TST_DSD HTS_TST_N_DSD_OtPITC_Age_Sex_Result 30-34, Male, Positive 2019 516
HTC_TST_DSD HTS_TST_N_DSD_OtPITC_Age_Sex_Result 35-39, Female, Negative 2019 8,627
HTC_TST_DSD HTS_TST_N_DSD_OtPITC_Age_Sex_Result 35-39, Female, Positive 2019 239
HTC_TST_DSD HTS_TST_N_DSD_OtPITC_Age_Sex_Result 35-39, Male, Negative 2019 7,274
HTC_TST_DSD HTS_TST_N_DSD_OtPITC_Age_Sex_Result 35-39, Male, Positive 2019 203
HTC_TST_DSD HTS_TST_N_DSD_OtPITC_Age_Sex_Result 40-49, Female, Negative 2019 8,627
HTC_TST_DSD HTS_TST_N_DSD_OtPITC_Age_Sex_Result 40-49, Female, Positive 2019 239
HTC_TST_DSD HTS_TST_N_DSD_OtPITC_Age_Sex_Result 40-49, Male, Negative 2019 2,425
HTC_TST_DSD HTS_TST_N_DSD_OtPITC_Age_Sex_Result 40-49, Male, Positive 2019 64
HTC_TST_DSD HTS_TST_N_DSD_PMTCT_Age_Sex_Result 25-29, Female, Negative 2019 8,405
HTC_TST_DSD HTS_TST_N_DSD_PMTCT_Age_Sex_Result 25-29, Female, Positive 2019 399
HTC_TST_DSD HTS_TST_N_DSD_PMTCT_Age_Sex_Result 30-34, Female, Negative 2019 8,405
HTC_TST_DSD HTS_TST_N_DSD_PMTCT_Age_Sex_Result 30-34, Female, Positive 2019 65
HTC_TST_DSD HTS_TST_N_DSD_PMTCT_Age_Sex_Result 35-39, Female, Negative 2019 8,405
HTC_TST_DSD HTS_TST_N_DSD_PMTCT_Age_Sex_Result 35-39, Female, Positive 2019 51
HTC_TST_DSD HTS_TST_N_DSD_PMTCT_Age_Sex_Result 40-49, Female, Negative 2019 8,405
HTC_TST_DSD HTS_TST_N_DSD_PMTCT_Age_Sex_Result 40-49, Female, Positive 2019 30
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 15-19, Female, Negative 2019 319
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 15-19, Female, Positive 2019 3
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 15-19, Male, Negative 2019 160
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 15-19, Male, Positive 2019 2
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 20-24, Female, Negative 2019 1,134
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 20-24, Female, Positive 2019 9
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 20-24, Male, Negative 2019 507
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 20-24, Male, Positive 2019 6
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 25-29, Female, Negative 2019 441
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 25-29, Female, Positive 2019 2
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 25-29, Male, Negative 2019 70
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 30-34, Female, Negative 2019 503
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 30-34, Female, Positive 2019 2
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 30-34, Male, Negative 2019 83
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 35-39, Female, Negative 2019 127
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 35-39, Male, Negative 2019 90
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 40-49, Female, Negative 2019 128
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 40-49, Male, Negative 2019 29
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 50+, Female, Negative 2019 61
HTC_TST_DSD HTS_TST_N_DSD_STI_Age_Sex_Result 50+, Male, Negative 2019 13
HTC_TST_DSD HTS_TST_N_DSD_TBC_Age_Sex_Result 25-29, Female, Negative 2019 209
HTC_TST_DSD HTS_TST_N_DSD_TBC_Age_Sex_Result 25-29, Female, Positive 2019 27
HTC_TST_DSD HTS_TST_N_DSD_TBC_Age_Sex_Result 25-29, Male, Negative 2019 293
HTC_TST_DSD HTS_TST_N_DSD_TBC_Age_Sex_Result 25-29, Male, Positive 2019 35
HTC_TST_DSD HTS_TST_N_DSD_TBC_Age_Sex_Result 30-34, Female, Negative 2019 193
HTC_TST_DSD HTS_TST_N_DSD_TBC_Age_Sex_Result 30-34, Female, Positive 2019 24
HTC_TST_DSD HTS_TST_N_DSD_TBC_Age_Sex_Result 30-34, Male, Negative 2019 310
HTC_TST_DSD HTS_TST_N_DSD_TBC_Age_Sex_Result 30-34, Male, Positive 2019 37
HTC_TST_DSD HTS_TST_N_DSD_TBC_Age_Sex_Result 35-39, Female, Negative 2019 234
HTC_TST_DSD HTS_TST_N_DSD_TBC_Age_Sex_Result 35-39, Female, Positive 2019 28
HTC_TST_DSD HTS_TST_N_DSD_TBC_Age_Sex_Result 35-39, Male, Negative 2019 424
HTC_TST_DSD HTS_TST_N_DSD_TBC_Age_Sex_Result 35-39, Male, Positive 2019 50
HTC_TST_DSD HTS_TST_N_DSD_TBC_Age_Sex_Result 40-49, Female, Negative 2019 192
HTC_TST_DSD HTS_TST_N_DSD_TBC_Age_Sex_Result 40-49, Female, Positive 2019 23
HTC_TST_DSD HTS_TST_N_DSD_TBC_Age_Sex_Result 40-49, Male, Negative 2019 388
HTC_TST_DSD HTS_TST_N_DSD_TBC_Age_Sex_Result 40-49, Male, Positive 2019 47
HTC_TST_DSD HTS_TST_N_DSD_VCT_Age_Sex_Result 25-29, Female, Negative 2019 8,461
HTC_TST_DSD HTS_TST_N_DSD_VCT_Age_Sex_Result 25-29, Female, Positive 2019 149
HTC_TST_DSD HTS_TST_N_DSD_VCT_Age_Sex_Result 25-29, Male, Negative 2019 1,297
HTC_TST_DSD HTS_TST_N_DSD_VCT_Age_Sex_Result 25-29, Male, Positive 2019 13
HTC_TST_DSD HTS_TST_N_DSD_VCT_Age_Sex_Result 30-34, Female, Negative 2019 9,629
HTC_TST_DSD HTS_TST_N_DSD_VCT_Age_Sex_Result 30-34, Female, Positive 2019 173
HTC_TST_DSD HTS_TST_N_DSD_VCT_Age_Sex_Result 30-34, Male, Negative 2019 1,566
HTC_TST_DSD HTS_TST_N_DSD_VCT_Age_Sex_Result 30-34, Male, Positive 2019 18
HTC_TST_DSD HTS_TST_N_DSD_VCT_Age_Sex_Result 35-39, Female, Negative 2019 2,478
HTC_TST_DSD HTS_TST_N_DSD_VCT_Age_Sex_Result 35-39, Female, Positive 2019 33
HTC_TST_DSD HTS_TST_N_DSD_VCT_Age_Sex_Result 35-39, Male, Negative 2019 1,585
HTC_TST_DSD HTS_TST_N_DSD_VCT_Age_Sex_Result 35-39, Male, Positive 2019 17
HTC_TST_DSD HTS_TST_N_DSD_VCT_Age_Sex_Result 40-49, Female, Negative 2019 2,446
HTC_TST_DSD HTS_TST_N_DSD_VCT_Age_Sex_Result 40-49, Female, Positive 2019 34
HTC_TST_DSD HTS_TST_N_DSD_VCT_Age_Sex_Result 40-49, Male, Negative 2019 521
HTC_TST_DSD HTS_TST_N_DSD_VCT_Age_Sex_Result 40-49, Male, Positive 2019 6
HTC_TST_DSD Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2019 473,494
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 15-19, Female, Negative 2019 8
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 15-19, Female, Positive 2019 1
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 20-24, Female, Negative 2019 27
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 20-24, Female, Positive 2019 3
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 20-24, Male, Negative 2019 1
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 50+, Female, Negative 2019 3
HTC_TST_DSD Service Delivery Point (Facility) ANC: 10-14, Negative 2019 109
HTC_TST_DSD Service Delivery Point (Facility) ANC: 15-19, Negative 2019 6,900
HTC_TST_DSD Service Delivery Point (Facility) ANC: 15-19, Positive 2019 50
HTC_TST_DSD Service Delivery Point (Facility) ANC: 20-24, Negative 2019 19,482
HTC_TST_DSD Service Delivery Point (Facility) ANC: 20-24, Positive 2019 204
HTC_TST_DSD Service Delivery Point (Facility) ANC: 50+, Negative 2019 336
HTC_TST_DSD Service Delivery Point (Facility) Index: 1-9, Negative 2019 514
HTC_TST_DSD Service Delivery Point (Facility) Index: 1-9, Positive 2019 15
HTC_TST_DSD Service Delivery Point (Facility) Index: 10-14, Female, Negative 2019 241
HTC_TST_DSD Service Delivery Point (Facility) Index: 10-14, Female, Positive 2019 7
HTC_TST_DSD Service Delivery Point (Facility) Index: 10-14, Male, Negative 2019 94
HTC_TST_DSD Service Delivery Point (Facility) Index: 10-14, Male, Positive 2019 2
HTC_TST_DSD Service Delivery Point (Facility) Index: 15-19, Female, Negative 2019 667
HTC_TST_DSD Service Delivery Point (Facility) Index: 15-19, Female, Positive 2019 218
HTC_TST_DSD Service Delivery Point (Facility) Index: 15-19, Male, Negative 2019 414
HTC_TST_DSD Service Delivery Point (Facility) Index: 15-19, Male, Positive 2019 125
HTC_TST_DSD Service Delivery Point (Facility) Index: 20-24, Female, Negative 2019 2,321
HTC_TST_DSD Service Delivery Point (Facility) Index: 20-24, Female, Positive 2019 729
HTC_TST_DSD Service Delivery Point (Facility) Index: 20-24, Male, Negative 2019 2,234
HTC_TST_DSD Service Delivery Point (Facility) Index: 20-24, Male, Positive 2019 424
HTC_TST_DSD Service Delivery Point (Facility) Index: 50+, Female, Negative 2019 110
HTC_TST_DSD Service Delivery Point (Facility) Index: 50+, Female, Positive 2019 38
HTC_TST_DSD Service Delivery Point (Facility) Index: 50+, Male, Negative 2019 31
HTC_TST_DSD Service Delivery Point (Facility) Index: 50+, Male, Positive 2019 12
HTC_TST_DSD Service Delivery Point (Facility) Index: <1, Negative 2019 167
HTC_TST_DSD Service Delivery Point (Facility) Index: <1, Positive 2019 5
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 1-9, Negative 2019 229
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 1-9, Positive 2019 2
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2019 93
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 10-14, Female, Positive 2019 1
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2019 44
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2019 2,635
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2019 48
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2019 1,506
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2019 33
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2019 9,033
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2019 217
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2019 4,830
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2019 105
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2019 430
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 50+, Female, Positive 2019 12
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2019 127
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 50+, Male, Positive 2019 2
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: <1, Negative 2019 78
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 1-9, Negative 2019 2,527
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 1-9, Positive 2019 40
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2019 967
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2019 14
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2019 487
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2019 5
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2019 16,446
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2019 470
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2019 21,928
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2019 613
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2019 85,351
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2019 2,415
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2019 43,509
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2019 1,206
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2019 4,313
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 50+, Female, Positive 2019 124
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2019 1,206
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2019 30
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: <1, Positive 2019 9
HTC_TST_DSD Service Delivery Point (Facility) Pediatric : <5 Negative 2019 2,257
HTC_TST_DSD Service Delivery Point (Facility) Pediatric : <5 Positive 2019 25
HTC_TST_DSD Service Delivery Point (Facility) TB: 1-9, Negative 2019 129
HTC_TST_DSD Service Delivery Point (Facility) TB: 1-9, Positive 2019 16
HTC_TST_DSD Service Delivery Point (Facility) TB: 10-14, Female, Negative 2019 153
HTC_TST_DSD Service Delivery Point (Facility) TB: 10-14, Female, Positive 2019 19
HTC_TST_DSD Service Delivery Point (Facility) TB: 10-14, Male, Negative 2019 140
HTC_TST_DSD Service Delivery Point (Facility) TB: 10-14, Male, Positive 2019 18
HTC_TST_DSD Service Delivery Point (Facility) TB: 15-19, Female, Negative 2019 224
HTC_TST_DSD Service Delivery Point (Facility) TB: 15-19, Female, Positive 2019 28
HTC_TST_DSD Service Delivery Point (Facility) TB: 15-19, Male, Negative 2019 274
HTC_TST_DSD Service Delivery Point (Facility) TB: 15-19, Male, Positive 2019 34
HTC_TST_DSD Service Delivery Point (Facility) TB: 20-24, Female, Negative 2019 222
HTC_TST_DSD Service Delivery Point (Facility) TB: 20-24, Female, Positive 2019 27
HTC_TST_DSD Service Delivery Point (Facility) TB: 20-24, Male, Negative 2019 275
HTC_TST_DSD Service Delivery Point (Facility) TB: 20-24, Male, Positive 2019 33
HTC_TST_DSD Service Delivery Point (Facility) TB: 50+, Female, Negative 2019 178
HTC_TST_DSD Service Delivery Point (Facility) TB: 50+, Female, Positive 2019 19
HTC_TST_DSD Service Delivery Point (Facility) TB: 50+, Male, Negative 2019 322
HTC_TST_DSD Service Delivery Point (Facility) TB: 50+, Male, Positive 2019 40
HTC_TST_DSD Service Delivery Point (Facility) VCT: 1-9, Negative 2019 216
HTC_TST_DSD Service Delivery Point (Facility) VCT: 1-9, Positive 2019 2
HTC_TST_DSD Service Delivery Point (Facility) VCT: 10-14, Female, Negative 2019 97
HTC_TST_DSD Service Delivery Point (Facility) VCT: 10-14, Female, Positive 2019 1
HTC_TST_DSD Service Delivery Point (Facility) VCT: 10-14, Male, Negative 2019 36
HTC_TST_DSD Service Delivery Point (Facility) VCT: 15-19, Female, Negative 2019 5,943
HTC_TST_DSD Service Delivery Point (Facility) VCT: 15-19, Female, Positive 2019 93
HTC_TST_DSD Service Delivery Point (Facility) VCT: 15-19, Male, Negative 2019 2,908
HTC_TST_DSD Service Delivery Point (Facility) VCT: 15-19, Male, Positive 2019 35
HTC_TST_DSD Service Delivery Point (Facility) VCT: 20-24, Female, Negative 2019 20,091
HTC_TST_DSD Service Delivery Point (Facility) VCT: 20-24, Female, Positive 2019 319
HTC_TST_DSD Service Delivery Point (Facility) VCT: 20-24, Male, Negative 2019 9,094
HTC_TST_DSD Service Delivery Point (Facility) VCT: 20-24, Male, Positive 2019 110
HTC_TST_DSD Service Delivery Point (Facility) VCT: 50+, Female, Negative 2019 1,219
HTC_TST_DSD Service Delivery Point (Facility) VCT: 50+, Female, Positive 2019 21
HTC_TST_DSD Service Delivery Point (Facility) VCT: 50+, Male, Negative 2019 264
HTC_TST_DSD Service Delivery Point (Facility) VCT: 50+, Male, Positive 2019 1
HTC_TST_DSD Service Delivery Point (Facility) VCT: <1, Negative 2019 71
HTC_TST_DSD Service Delivery Point (Facility)Other PITC: <1, Negative 2019 657
HTC_TST_TA HTS_TST_N_TA_Index_Age_Sex_Result 25-29, Female, Negative 2019 234
HTC_TST_TA HTS_TST_N_TA_Index_Age_Sex_Result 25-29, Female, Positive 2019 64
HTC_TST_TA HTS_TST_N_TA_Index_Age_Sex_Result 25-29, Male, Negative 2019 37
HTC_TST_TA HTS_TST_N_TA_Index_Age_Sex_Result 25-29, Male, Positive 2019 11
HTC_TST_TA HTS_TST_N_TA_Index_Age_Sex_Result 30-34, Female, Negative 2019 261
HTC_TST_TA HTS_TST_N_TA_Index_Age_Sex_Result 30-34, Female, Positive 2019 70
HTC_TST_TA HTS_TST_N_TA_Index_Age_Sex_Result 30-34, Male, Negative 2019 47
HTC_TST_TA HTS_TST_N_TA_Index_Age_Sex_Result 30-34, Male, Positive 2019 9
HTC_TST_TA HTS_TST_N_TA_Index_Age_Sex_Result 35-39, Female, Negative 2019 71
HTC_TST_TA HTS_TST_N_TA_Index_Age_Sex_Result 35-39, Female, Positive 2019 14
HTC_TST_TA HTS_TST_N_TA_Index_Age_Sex_Result 35-39, Male, Negative 2019 44
HTC_TST_TA HTS_TST_N_TA_Index_Age_Sex_Result 35-39, Male, Positive 2019 10
HTC_TST_TA HTS_TST_N_TA_Index_Age_Sex_Result 40-49, Female, Negative 2019 68
HTC_TST_TA HTS_TST_N_TA_Index_Age_Sex_Result 40-49, Female, Positive 2019 13
HTC_TST_TA HTS_TST_N_TA_Index_Age_Sex_Result 40-49, Male, Negative 2019 16
HTC_TST_TA HTS_TST_N_TA_Index_Age_Sex_Result 40-49, Male, Positive 2019 5
HTC_TST_TA HTS_TST_N_TA_Inpat_Age_Sex_Result 25-29, Female, Negative 2019 496
HTC_TST_TA HTS_TST_N_TA_Inpat_Age_Sex_Result 25-29, Female, Positive 2019 8
HTC_TST_TA HTS_TST_N_TA_Inpat_Age_Sex_Result 25-29, Male, Negative 2019 77
HTC_TST_TA HTS_TST_N_TA_Inpat_Age_Sex_Result 30-34, Female, Negative 2019 453
HTC_TST_TA HTS_TST_N_TA_Inpat_Age_Sex_Result 30-34, Female, Positive 2019 8
HTC_TST_TA HTS_TST_N_TA_Inpat_Age_Sex_Result 30-34, Male, Negative 2019 90
HTC_TST_TA HTS_TST_N_TA_Inpat_Age_Sex_Result 35-39, Female, Negative 2019 112
HTC_TST_TA HTS_TST_N_TA_Inpat_Age_Sex_Result 35-39, Female, Positive 2019 1
HTC_TST_TA HTS_TST_N_TA_Inpat_Age_Sex_Result 35-39, Male, Negative 2019 92
HTC_TST_TA HTS_TST_N_TA_Inpat_Age_Sex_Result 40-49, Female, Negative 2019 112
HTC_TST_TA HTS_TST_N_TA_Inpat_Age_Sex_Result 40-49, Male, Negative 2019 26
HTC_TST_TA HTS_TST_N_TA_PMTCT_Age_Sex_Result 25-29, Female, Negative 2019 777
HTC_TST_TA HTS_TST_N_TA_PMTCT_Age_Sex_Result 25-29, Female, Positive 2019 23
HTC_TST_TA HTS_TST_N_TA_PMTCT_Age_Sex_Result 30-34, Female, Negative 2019 777
HTC_TST_TA HTS_TST_N_TA_PMTCT_Age_Sex_Result 30-34, Female, Positive 2019 7
HTC_TST_TA HTS_TST_N_TA_PMTCT_Age_Sex_Result 35-39, Female, Negative 2019 777
HTC_TST_TA HTS_TST_N_TA_PMTCT_Age_Sex_Result 35-39, Female, Positive 2019 6
HTC_TST_TA HTS_TST_N_TA_PMTCT_Age_Sex_Result 40-49, Female, Negative 2019 777
HTC_TST_TA HTS_TST_N_TA_PMTCT_Age_Sex_Result 40-49, Female, Positive 2019 4
HTC_TST_TA HTS_TST_N_TA_STI_Age_Sex_Result 15-19, Female, Negative 2019 76
HTC_TST_TA HTS_TST_N_TA_STI_Age_Sex_Result 15-19, Male, Negative 2019 33
HTC_TST_TA HTS_TST_N_TA_STI_Age_Sex_Result 20-24, Female, Negative 2019 280
HTC_TST_TA HTS_TST_N_TA_STI_Age_Sex_Result 20-24, Male, Negative 2019 123
HTC_TST_TA HTS_TST_N_TA_STI_Age_Sex_Result 25-29, Female, Negative 2019 99
HTC_TST_TA HTS_TST_N_TA_STI_Age_Sex_Result 25-29, Male, Negative 2019 14
HTC_TST_TA HTS_TST_N_TA_STI_Age_Sex_Result 30-34, Female, Negative 2019 113
HTC_TST_TA HTS_TST_N_TA_STI_Age_Sex_Result 30-34, Male, Negative 2019 20
HTC_TST_TA HTS_TST_N_TA_STI_Age_Sex_Result 35-39, Female, Negative 2019 25
HTC_TST_TA HTS_TST_N_TA_STI_Age_Sex_Result 35-39, Male, Negative 2019 17
HTC_TST_TA HTS_TST_N_TA_STI_Age_Sex_Result 40-49, Female, Negative 2019 24
HTC_TST_TA HTS_TST_N_TA_STI_Age_Sex_Result 40-49, Male, Negative 2019 2
HTC_TST_TA HTS_TST_N_TA_STI_Age_Sex_Result 50+, Female, Negative 2019 11
HTC_TST_TA HTS_TST_N_TA_TBC_Age_Sex_Result 25-29, Female, Negative 2019 24
HTC_TST_TA HTS_TST_N_TA_TBC_Age_Sex_Result 25-29, Female, Positive 2019 1
HTC_TST_TA HTS_TST_N_TA_TBC_Age_Sex_Result 25-29, Male, Negative 2019 27
HTC_TST_TA HTS_TST_N_TA_TBC_Age_Sex_Result 25-29, Male, Positive 2019 2
HTC_TST_TA HTS_TST_N_TA_TBC_Age_Sex_Result 30-34, Female, Negative 2019 21
HTC_TST_TA HTS_TST_N_TA_TBC_Age_Sex_Result 30-34, Female, Positive 2019 1
HTC_TST_TA HTS_TST_N_TA_TBC_Age_Sex_Result 30-34, Male, Negative 2019 28
HTC_TST_TA HTS_TST_N_TA_TBC_Age_Sex_Result 30-34, Male, Positive 2019 2
HTC_TST_TA HTS_TST_N_TA_TBC_Age_Sex_Result 35-39, Female, Negative 2019 26
HTC_TST_TA HTS_TST_N_TA_TBC_Age_Sex_Result 35-39, Female, Positive 2019 2
HTC_TST_TA HTS_TST_N_TA_TBC_Age_Sex_Result 35-39, Male, Negative 2019 44
HTC_TST_TA HTS_TST_N_TA_TBC_Age_Sex_Result 35-39, Male, Positive 2019 3
HTC_TST_TA HTS_TST_N_TA_TBC_Age_Sex_Result 40-49, Female, Negative 2019 21
HTC_TST_TA HTS_TST_N_TA_TBC_Age_Sex_Result 40-49, Female, Positive 2019 2
HTC_TST_TA HTS_TST_N_TA_TBC_Age_Sex_Result 40-49, Male, Negative 2019 38
HTC_TST_TA HTS_TST_N_TA_TBC_Age_Sex_Result 40-49, Male, Positive 2019 3
HTC_TST_TA HTS_TST_N_TA_VCT_Age_Sex_Result 25-29, Female, Negative 2019 1,366
HTC_TST_TA HTS_TST_N_TA_VCT_Age_Sex_Result 25-29, Female, Positive 2019 15
HTC_TST_TA HTS_TST_N_TA_VCT_Age_Sex_Result 25-29, Male, Negative 2019 214
HTC_TST_TA HTS_TST_N_TA_VCT_Age_Sex_Result 30-34, Female, Negative 2019 1,603
HTC_TST_TA HTS_TST_N_TA_VCT_Age_Sex_Result 30-34, Female, Positive 2019 15
HTC_TST_TA HTS_TST_N_TA_VCT_Age_Sex_Result 30-34, Male, Negative 2019 253
HTC_TST_TA HTS_TST_N_TA_VCT_Age_Sex_Result 35-39, Female, Negative 2019 329
HTC_TST_TA HTS_TST_N_TA_VCT_Age_Sex_Result 35-39, Female, Positive 2019 2
HTC_TST_TA HTS_TST_N_TA_VCT_Age_Sex_Result 35-39, Male, Negative 2019 234
HTC_TST_TA HTS_TST_N_TA_VCT_Age_Sex_Result 35-39, Male, Positive 2019 1
HTC_TST_TA HTS_TST_N_TA_VCT_Age_Sex_Result 40-49, Female, Negative 2019 361
HTC_TST_TA HTS_TST_N_TA_VCT_Age_Sex_Result 40-49, Female, Positive 2019 1
HTC_TST_TA HTS_TST_N_TA_VCT_Age_Sex_Result 40-49, Male, Negative 2019 82
HTC_TST_TA Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2019 24,963
HTC_TST_TA Service Delivery Point (Facility) ANC: 10-14, Negative 2019 3
HTC_TST_TA Service Delivery Point (Facility) ANC: 15-19, Negative 2019 595
HTC_TST_TA Service Delivery Point (Facility) ANC: 20-24, Negative 2019 1,789
HTC_TST_TA Service Delivery Point (Facility) ANC: 20-24, Positive 2019 13
HTC_TST_TA Service Delivery Point (Facility) ANC: 50+, Negative 2019 61
HTC_TST_TA Service Delivery Point (Facility) Index: 1-9, Negative 2019 213
HTC_TST_TA Service Delivery Point (Facility) Index: 1-9, Positive 2019 2
HTC_TST_TA Service Delivery Point (Facility) Index: 10-14, Female, Negative 2019 61
HTC_TST_TA Service Delivery Point (Facility) Index: 10-14, Male, Negative 2019 25
HTC_TST_TA Service Delivery Point (Facility) Index: 15-19, Female, Negative 2019 192
HTC_TST_TA Service Delivery Point (Facility) Index: 15-19, Female, Positive 2019 51
HTC_TST_TA Service Delivery Point (Facility) Index: 15-19, Male, Negative 2019 100
HTC_TST_TA Service Delivery Point (Facility) Index: 15-19, Male, Positive 2019 32
HTC_TST_TA Service Delivery Point (Facility) Index: 20-24, Female, Negative 2019 645
HTC_TST_TA Service Delivery Point (Facility) Index: 20-24, Female, Positive 2019 175
HTC_TST_TA Service Delivery Point (Facility) Index: 20-24, Male, Negative 2019 645
HTC_TST_TA Service Delivery Point (Facility) Index: 20-24, Male, Positive 2019 110
HTC_TST_TA Service Delivery Point (Facility) Index: 50+, Female, Negative 2019 28
HTC_TST_TA Service Delivery Point (Facility) Index: 50+, Female, Positive 2019 8
HTC_TST_TA Service Delivery Point (Facility) Index: 50+, Male, Negative 2019 9
HTC_TST_TA Service Delivery Point (Facility) Index: <1, Negative 2019 29
HTC_TST_TA Service Delivery Point (Facility) Inpatient: 1-9, Negative 2019 29
HTC_TST_TA Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2019 6
HTC_TST_TA Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2019 4
HTC_TST_TA Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2019 335
HTC_TST_TA Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2019 3
HTC_TST_TA Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2019 193
HTC_TST_TA Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2019 4
HTC_TST_TA Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2019 1,195
HTC_TST_TA Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2019 26
HTC_TST_TA Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2019 617
HTC_TST_TA Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2019 12
HTC_TST_TA Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2019 62
HTC_TST_TA Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2019 14
HTC_TST_TA Service Delivery Point (Facility) Inpatient: <1, Negative 2019 15
HTC_TST_TA Service Delivery Point (Facility) TB: 1-9, Negative 2019 8
HTC_TST_TA Service Delivery Point (Facility) TB: 10-14, Female, Negative 2019 14
HTC_TST_TA Service Delivery Point (Facility) TB: 10-14, Male, Negative 2019 14
HTC_TST_TA Service Delivery Point (Facility) TB: 15-19, Female, Negative 2019 20
HTC_TST_TA Service Delivery Point (Facility) TB: 15-19, Male, Negative 2019 28
HTC_TST_TA Service Delivery Point (Facility) TB: 15-19, Male, Positive 2019 1
HTC_TST_TA Service Delivery Point (Facility) TB: 20-24, Female, Negative 2019 22
HTC_TST_TA Service Delivery Point (Facility) TB: 20-24, Female, Positive 2019 1
HTC_TST_TA Service Delivery Point (Facility) TB: 20-24, Male, Negative 2019 27
HTC_TST_TA Service Delivery Point (Facility) TB: 20-24, Male, Positive 2019 2
HTC_TST_TA Service Delivery Point (Facility) TB: 50+, Female, Negative 2019 20
HTC_TST_TA Service Delivery Point (Facility) TB: 50+, Female, Positive 2019 2
HTC_TST_TA Service Delivery Point (Facility) TB: 50+, Male, Negative 2019 29
HTC_TST_TA Service Delivery Point (Facility) TB: 50+, Male, Positive 2019 2
HTC_TST_TA Service Delivery Point (Facility) VCT: 1-9, Negative 2019 17
HTC_TST_TA Service Delivery Point (Facility) VCT: 10-14, Female, Negative 2019 9
HTC_TST_TA Service Delivery Point (Facility) VCT: 10-14, Male, Negative 2019 3
HTC_TST_TA Service Delivery Point (Facility) VCT: 15-19, Female, Negative 2019 842
HTC_TST_TA Service Delivery Point (Facility) VCT: 15-19, Female, Positive 2019 12
HTC_TST_TA Service Delivery Point (Facility) VCT: 15-19, Male, Negative 2019 397
HTC_TST_TA Service Delivery Point (Facility) VCT: 15-19, Male, Positive 2019 3
HTC_TST_TA Service Delivery Point (Facility) VCT: 20-24, Female, Negative 2019 3,271
HTC_TST_TA Service Delivery Point (Facility) VCT: 20-24, Female, Positive 2019 35
HTC_TST_TA Service Delivery Point (Facility) VCT: 20-24, Male, Negative 2019 1,489
HTC_TST_TA Service Delivery Point (Facility) VCT: 20-24, Male, Positive 2019 15
HTC_TST_TA Service Delivery Point (Facility) VCT: 50+, Female, Negative 2019 177
HTC_TST_TA Service Delivery Point (Facility) VCT: 50+, Male, Negative 2019 38
HTC_TST_TA Service Delivery Point (Facility) VCT: <1, Negative 2019 9
HTS_SELF_DSD HTS_SELF_N_DSD 2019 1,736
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 15-19, Female, Directly-Assisted 2019 93
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 15-19, Female, Unassisted 2019 93
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 15-19, Male, Directly-Assisted 2019 32
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 15-19, Male, Unassisted 2019 32
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 20-24, Female, Directly-Assisted 2019 93
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 20-24, Female, Unassisted 2019 93
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 20-24, Male, Directly-Assisted 2019 32
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 20-24, Male, Unassisted 2019 32
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 25-29, Female, Directly-Assisted 2019 93
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 25-29, Female, Unassisted 2019 93
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 25-29, Male, Directly-Assisted 2019 32
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 25-29, Male, Unassisted 2019 32
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 30-34, Female, Directly-Assisted 2019 93
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 30-34, Female, Unassisted 2019 93
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 30-34, Male, Directly-Assisted 2019 32
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 30-34, Male, Unassisted 2019 32
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 35-39, Female, Directly-Assisted 2019 93
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 35-39, Female, Unassisted 2019 93
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 35-39, Male, Directly-Assisted 2019 32
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 35-39, Male, Unassisted 2019 32
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 40-49, Female, Directly-Assisted 2019 93
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 40-49, Female, Unassisted 2019 93
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 40-49, Male, Directly-Assisted 2019 32
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 40-49, Male, Unassisted 2019 32
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 50+, Female, Directly-Assisted 2019 93
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 50+, Female, Unassisted 2019 93
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 50+, Male, Directly-Assisted 2019 32
HTS_SELF_DSD HTS_SELF_N_DSD_Age_Sex_HIVSelfTest 50+, Male, Unassisted 2019 32
HTS_SELF_DSD HTS_SELF_N_DSD_HIVSelfTest Directly-Assisted 2019 868
HTS_SELF_DSD HTS_SELF_N_DSD_HIVSelfTest Unassisted 2019 868
HTS_SELF_DSD HTS_SELF_N_DSD_HIVSelfTestUser Unassisted - Other 2019 87
HTS_SELF_DSD HTS_SELF_N_DSD_HIVSelfTestUser Unassisted - Self 2019 437
HTS_SELF_DSD HTS_SELF_N_DSD_HIVSelfTestUser Unassisted - Sex Partner 2019 348
HTS_SELF_DSD HTS_SELF_N_DSD_KeyPop_HIVSelfTest FSW, Directly-Assisted 2019 1,166
HTS_SELF_DSD HTS_SELF_N_DSD_KeyPop_HIVSelfTest MSM, Directly-Assisted 2019 261
HTS_SELF_DSD HTS_SELF_N_DSD_KeyPop_HIVSelfTest PWID, Directly-Assisted 2019 104
PMTCT_ART_DSD Already on ART at beginning of current pregnancy 2019 1,300
PMTCT_ART_DSD New on ART 2019 817
PMTCT_ART_DSD Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2019 2,117
PMTCT_ART_DSD Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 68,100
PMTCT_EID_DSD By infants who received their first virologic HIV test between 2 and 12 months of age 2019 438
PMTCT_EID_DSD Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2019 438
PMTCT_EID_DSD Sum of Infant Age disaggregates 2019 438
PMTCT_STAT_DSD By Age (Denominator): 10-14 2019 39
PMTCT_STAT_DSD By Age (Denominator): 20-24 2019 22,003
PMTCT_STAT_DSD By Age (Denominator): 50+ 2019 384
PMTCT_STAT_DSD By Age (Denominator): <15-19 2019 8,502
PMTCT_STAT_DSD By Age (Numerator): 10-14 2019 94
PMTCT_STAT_DSD By Age (Numerator): 15-19 2019 7,527
PMTCT_STAT_DSD By Age (Numerator): 20-24 2019 21,622
PMTCT_STAT_DSD By Age (Numerator): 50+ 2019 496
PMTCT_STAT_DSD By Number of known positives: 15-19 2019 42
PMTCT_STAT_DSD By Number of known positives: 20-24 2019 211
PMTCT_STAT_DSD By Number of new negative: 10-14 2019 103
PMTCT_STAT_DSD By Number of new negative: 15-19 2019 7,389
PMTCT_STAT_DSD By Number of new negative: 20-24 2019 21,131
PMTCT_STAT_DSD By Number of new negative: 50+ 2019 490
PMTCT_STAT_DSD By Number of new positives: 10-14 2019 1
PMTCT_STAT_DSD By Number of new positives: 15-19 2019 94
PMTCT_STAT_DSD By Number of new positives: 20-24 2019 279
PMTCT_STAT_DSD By Number of new positives: 50+ 2019 6
PMTCT_STAT_DSD Number of new ANC and L&D clients 2019 69,748
PMTCT_STAT_DSD Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 68,100
PMTCT_STAT_DSD PMTCT_STAT_D_DSD_Age_Sex 25-29, Female 2019 9,705
PMTCT_STAT_DSD PMTCT_STAT_D_DSD_Age_Sex 30-34, Female 2019 9,705
PMTCT_STAT_DSD PMTCT_STAT_D_DSD_Age_Sex 35-39, Female 2019 9,705
PMTCT_STAT_DSD PMTCT_STAT_D_DSD_Age_Sex 40-49, Female 2019 9,705
PMTCT_STAT_DSD PMTCT_STAT_N_DSD_Age_Sex 25-29, Female 2019 9,954
PMTCT_STAT_DSD PMTCT_STAT_N_DSD_Age_Sex 30-34, Female 2019 9,593
PMTCT_STAT_DSD PMTCT_STAT_N_DSD_Age_Sex 35-39, Female 2019 9,593
PMTCT_STAT_DSD PMTCT_STAT_N_DSD_Age_Sex 40-49, Female 2019 9,593
PMTCT_STAT_DSD PMTCT_STAT_N_DSD_Age_Sex_KnownNewResult 25-29, Female, Known at Entry Positive 2019 280
PMTCT_STAT_DSD PMTCT_STAT_N_DSD_Age_Sex_KnownNewResult 25-29, Female, Newly Identified Negative 2019 9,212
PMTCT_STAT_DSD PMTCT_STAT_N_DSD_Age_Sex_KnownNewResult 25-29, Female, Newly Identified Positive 2019 114
PMTCT_STAT_DSD PMTCT_STAT_N_DSD_Age_Sex_KnownNewResult 30-34, Female, Known at Entry Positive 2019 280
PMTCT_STAT_DSD PMTCT_STAT_N_DSD_Age_Sex_KnownNewResult 30-34, Female, Newly Identified Negative 2019 9,212
PMTCT_STAT_DSD PMTCT_STAT_N_DSD_Age_Sex_KnownNewResult 30-34, Female, Newly Identified Positive 2019 114
PMTCT_STAT_DSD PMTCT_STAT_N_DSD_Age_Sex_KnownNewResult 35-39, Female, Known at Entry Positive 2019 280
PMTCT_STAT_DSD PMTCT_STAT_N_DSD_Age_Sex_KnownNewResult 35-39, Female, Newly Identified Negative 2019 9,212
PMTCT_STAT_DSD PMTCT_STAT_N_DSD_Age_Sex_KnownNewResult 35-39, Female, Newly Identified Positive 2019 114
PMTCT_STAT_DSD PMTCT_STAT_N_DSD_Age_Sex_KnownNewResult 40-49, Female, Known at Entry Positive 2019 280
PMTCT_STAT_DSD PMTCT_STAT_N_DSD_Age_Sex_KnownNewResult 40-49, Female, Newly Identified Negative 2019 9,212
PMTCT_STAT_DSD PMTCT_STAT_N_DSD_Age_Sex_KnownNewResult 40-49, Female, Newly Identified Positive 2019 114
PP_PREV_DSD Age/sex: 10-14 Female 2019 20
PP_PREV_DSD Age/sex: 10-14 Male 2019 6
PP_PREV_DSD Age/sex: 15-19 Female 2019 148
PP_PREV_DSD Age/sex: 15-19 Male 2019 22
PP_PREV_DSD Age/sex: 20-24 Female 2019 479
PP_PREV_DSD Age/sex: 20-24 Male 2019 264
PP_PREV_DSD Age/sex: 50+ Female 2019 120
PP_PREV_DSD Age/sex: 50+ Male 2019 37
PP_PREV_DSD Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2019 6,134
PP_PREV_DSD PP_PREV_N_DSD_Age_Sex_v2 25-29, Female 2019 147
PP_PREV_DSD PP_PREV_N_DSD_Age_Sex_v2 25-29, Male 2019 107
PP_PREV_DSD PP_PREV_N_DSD_Age_Sex_v2 30-34, Female 2019 147
PP_PREV_DSD PP_PREV_N_DSD_Age_Sex_v2 30-34, Male 2019 107
PP_PREV_DSD PP_PREV_N_DSD_Age_Sex_v2 35-39, Female 2019 147
PP_PREV_DSD PP_PREV_N_DSD_Age_Sex_v2 35-39, Male 2019 107
PP_PREV_DSD PP_PREV_N_DSD_Age_Sex_v2 40-49, Female 2019 147
PP_PREV_DSD PP_PREV_N_DSD_Age_Sex_v2 40-49, Male 2019 107
PP_PREV_DSD Sum of Age/Sex disaggregates 2019 1,096
PrEP_NEW_DSD Female 15-19 2019 242
PrEP_NEW_DSD Female 20-24 2019 824
PrEP_NEW_DSD Female 50+ 2019 40
PrEP_NEW_DSD FSW 2019 279
PrEP_NEW_DSD Male 15-19 2019 20
PrEP_NEW_DSD Male 20-24 2019 120
PrEP_NEW_DSD Male 50+ 2019 40
PrEP_NEW_DSD MSM 2019 144
PrEP_NEW_DSD Number of individuals who have been newly enrolled on oral antiretroviral pre-exposure prophylaxis (PrEP) in the reporting period to prevent HIV infection 2019 2,009
PrEP_NEW_DSD PrEP_NEW_N_DSD_Age_Sex_v2 25-29, Female 2019 142
PrEP_NEW_DSD PrEP_NEW_N_DSD_Age_Sex_v2 25-29, Male 2019 59
PrEP_NEW_DSD PrEP_NEW_N_DSD_Age_Sex_v2 30-34, Female 2019 101
PrEP_NEW_DSD PrEP_NEW_N_DSD_Age_Sex_v2 30-34, Male 2019 80
PrEP_NEW_DSD PrEP_NEW_N_DSD_Age_Sex_v2 35-39, Female 2019 101
PrEP_NEW_DSD PrEP_NEW_N_DSD_Age_Sex_v2 35-39, Male 2019 80
PrEP_NEW_DSD PrEP_NEW_N_DSD_Age_Sex_v2 40-49, Female 2019 102
PrEP_NEW_DSD PrEP_NEW_N_DSD_Age_Sex_v2 40-49, Male 2019 58
TB_ART_DSD Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 402
TB_ART_DSD Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 525
TB_ART_DSD The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2019 940
TB_PREV_DSD By Age/Sex (Denominator): 15+, Female 2019 6,788
TB_PREV_DSD By Age/Sex (Denominator): 15+, Male 2019 3,242
TB_PREV_DSD By Age/Sex (Denominator): <15, Female 2019 515
TB_PREV_DSD By Age/Sex (Denominator): <15, Male 2019 438
TB_PREV_DSD By Age/Sex (Numerator): 15+, Female 2019 4,122
TB_PREV_DSD By Age/Sex (Numerator): 15+, Male 2019 1,947
TB_PREV_DSD By Age/Sex (Numerator): <15, Female 2019 309
TB_PREV_DSD By Age/Sex (Numerator): <15, Male 2019 257
TB_PREV_DSD TB_PREV_D_DSD_TherapyType_NewExArt_HIV IPT, Life-long ART, New, Positive 2019 10,983
TB_PREV_DSD The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2019 6,638
TB_PREV_DSD The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2019 10,983
TB_STAT_DSD Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 1,474
TB_STAT_DSD Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 1,482
TB_STAT_DSD Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 261
TB_STAT_DSD Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 260
TB_STAT_DSD Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 3,341
TB_STAT_DSD Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 3,319
TB_STAT_DSD Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 282
TB_STAT_DSD Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 276
TB_STAT_DSD Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2019 5,353
TB_STAT_DSD Total number of registered new and relapsed TB cases, during the reporting period 2019 5,357
TX_CURR_DSD Age/Sex: 10-14 Female 2019 972
TX_CURR_DSD Age/Sex: 10-14 Male 2019 975
TX_CURR_DSD Age/Sex: 15-19 Female 2019 1,308
TX_CURR_DSD Age/Sex: 15-19 Male 2019 720
TX_CURR_DSD Age/Sex: 20-24 Female 2019 3,642
TX_CURR_DSD Age/Sex: 20-24 Male 2019 944
TX_CURR_DSD Age/Sex: 50+ Female 2019 3,900
TX_CURR_DSD Age/Sex: 50+ Male 2019 1,004
TX_CURR_DSD Age/Sex: <1 2019 35
TX_CURR_DSD Age/Sex: <1-9 2019 1,610
TX_CURR_DSD Number of adults and children receiving antiretroviral therapy (ART) 2019 53,781
TX_CURR_DSD Sum of age/sex disaggregates 2019 2,028
TX_CURR_DSD TX_CURR_N_DSD_Age_Sex_HIVStatus 25-29, Female, Positive 2019 9,415
TX_CURR_DSD TX_CURR_N_DSD_Age_Sex_HIVStatus 25-29, Male, Positive 2019 1,775
TX_CURR_DSD TX_CURR_N_DSD_Age_Sex_HIVStatus 30-34, Female, Positive 2019 7,143
TX_CURR_DSD TX_CURR_N_DSD_Age_Sex_HIVStatus 30-34, Male, Positive 2019 2,780
TX_CURR_DSD TX_CURR_N_DSD_Age_Sex_HIVStatus 35-39, Female, Positive 2019 7,143
TX_CURR_DSD TX_CURR_N_DSD_Age_Sex_HIVStatus 35-39, Male, Positive 2019 2,780
TX_CURR_DSD TX_CURR_N_DSD_Age_Sex_HIVStatus 40-49, Female, Positive 2019 4,871
TX_CURR_DSD TX_CURR_N_DSD_Age_Sex_HIVStatus 40-49, Male, Positive 2019 2,781
TX_NEW_DSD Breastfeeding status 2019 187
TX_NEW_DSD By Age/Sex: 1-9 2019 78
TX_NEW_DSD By Age/Sex: 10-14 Female 2019 27
TX_NEW_DSD By Age/Sex: 10-14 Male 2019 8
TX_NEW_DSD By Age/Sex: 15-19 Female 2019 1,253
TX_NEW_DSD By Age/Sex: 15-19 Male 2019 660
TX_NEW_DSD By Age/Sex: 20-24 Female 2019 4,348
TX_NEW_DSD By Age/Sex: 20-24 Male 2019 2,145
TX_NEW_DSD By Age/Sex: 50+ Female 2019 214
TX_NEW_DSD By Age/Sex: 50+ Male 2019 52
TX_NEW_DSD By Age/Sex: <1 2019 53
TX_NEW_DSD By Key populations: People who inject drugs (PWID) 2019 3
TX_NEW_DSD FSW 2019 106
TX_NEW_DSD MSM 2019 35
TX_NEW_DSD Number of adults and children newly enrolled on antiretroviral therapy (ART) 2019 13,946
TX_NEW_DSD People in prisons and other enclosed settings 2019 207
TX_NEW_DSD Pregnancy status 2019 728
TX_NEW_DSD Sum of Age/Sex disaggregates 2019 8,707
TX_NEW_DSD TX_NEW_N_DSD_Age_Sex_HIVStatus 25-29, Female, Positive 2019 1,429
TX_NEW_DSD TX_NEW_N_DSD_Age_Sex_HIVStatus 25-29, Male, Positive 2019 265
TX_NEW_DSD TX_NEW_N_DSD_Age_Sex_HIVStatus 30-34, Female, Positive 2019 1,654
TX_NEW_DSD TX_NEW_N_DSD_Age_Sex_HIVStatus 30-34, Male, Positive 2019 315
TX_NEW_DSD TX_NEW_N_DSD_Age_Sex_HIVStatus 35-39, Female, Positive 2019 428
TX_NEW_DSD TX_NEW_N_DSD_Age_Sex_HIVStatus 35-39, Male, Positive 2019 342
TX_NEW_DSD TX_NEW_N_DSD_Age_Sex_HIVStatus 40-49, Female, Positive 2019 427
TX_NEW_DSD TX_NEW_N_DSD_Age_Sex_HIVStatus 40-49, Male, Positive 2019 106
TX_PVLS_DSD 15+, Undocumented Test Indication, Female 2019 1,121
TX_PVLS_DSD 15+, Undocumented Test Indication, Male 2019 346
TX_PVLS_DSD <15, Undocumented Test Indication, Female 2019 105
TX_PVLS_DSD <15, Undocumented Test Indication, Male 2019 73
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2019 26,617
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2019 1,450
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2019 10,442
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2019 1,199
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2019 1,718
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2019 51
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2019 1,671
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2019 44
TX_PVLS_DSD Denominator: Indication: Routine 2019 40,448
TX_PVLS_DSD Denominator: Indication: Targeted 2019 2,744
TX_PVLS_DSD Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2019 44,837
TX_PVLS_DSD Undocumented Test Indication 2019 1,645
TX_RET_DSD Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 6,389
TX_RET_DSD Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 311
TX_RET_DSD Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 3,385
TX_RET_DSD Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 144
TX_RET_DSD Denominator by Status: Breastfeeding 2019 64
TX_RET_DSD Denominator by Status: Pregnant 2019 897
TX_RET_DSD Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2019 9,194
TX_RET_DSD Numerator by Status: Breastfeeding 2019 60
TX_RET_DSD Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2019 10,280
TX_TB_DSD Denominator: By Aggregated Age/Sex: <15, Female 2019 1,965
TX_TB_DSD Denominator: By Aggregated Age/Sex: <15, Male 2019 2,120
TX_TB_DSD Denominator: By Aggregated Age/Sex:15+, Female 2019 34,100
TX_TB_DSD Denominator: By Aggregated Age/Sex:15+, Male 2019 15,583
TX_TB_DSD Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2019 1,136
TX_TB_DSD Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2019 155
TX_TB_DSD Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2019 1,351
TX_TB_DSD Number of ART patients who were screened for TB at least once during the reporting period 2019 53,779
Cross Cutting Budget Categories and Known Amounts Total: $973,273
Gender: Gender Based Violence (GBV) $69,187
GBV Prevention
Capacity building
Monitoring and Evaluation
Post GBV Care
Adolescent Girls and Young Women (AGYW) $904,086